Publication: 837

Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial
      QxMD   Google Scholar   
Citation:
J Clin Oncol vol 28 (23) 3673-3679
Year:
2010
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
822  
Children:
None
Program:
CCP
Primary Committee:
Symptom Inter
Sec. Committees:
   
Pharmas:
 
Grants:
 
Corr. Author:
 
Authors:
                           
Networks:
 
Study
NCCTG-N05C7
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: